3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Renal Insufficiency, Chronic
1
Renal Insufficiency
1
Lymphoma, Follicular
1
Heart Failure
1
Interventions
glucarpidase
2
safinamide
1
sacubitril and valsartan sodium hydrate drug combination
1
ripretinib
1
mirabegron
1
gamma-Glutamyl Hydrolase
1
Sitagliptin Phosphate
1
Rituximab
1
Methotrexate
1
Leucovorin
1
Lenalidomide
1
Eplerenone
1
Duration of Therapy
1
Cyclophosphamide
1
Cilengitide
1
Carboxypeptidases
1
Bendamustine Hydrochloride
1
Azacitidine
1
3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Renal Insufficiency
×
Eplerenone
×
Lymphoid
×
Clear all
NCT07029503
2026-02-24
SCARF-1
Karolinska Institutet
Phase 2
Recruiting
40 enrolled